Other

Other

Boston Scientific Other decreased by 18.8% to $379.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 34.4%, from $282.00M to $379.00M. Over 4 years (FY 2020 to FY 2024), Other shows relatively stable performance with a 0.5% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2019
Last reportedQ3 2025
Metric ID: other_other_sundry_liabilities_current

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$268.00M$255.00M$228.00M$241.00M$193.00M$220.00M$230.00M$217.00M$242.00M$234.00M$278.00M$246.00M$222.00M$282.00M$313.00M$302.00M$467.00M$379.00M
QoQ Change-4.9%-10.6%+5.7%-19.9%+14.0%+4.5%-5.7%+11.5%-3.3%+18.8%-11.5%-9.8%+27.0%+11.0%-3.5%+54.6%-18.8%
YoY Change-28.0%-13.7%+0.9%-10.0%+25.4%+6.4%+20.9%+13.4%-8.3%+20.5%+12.6%+22.8%+110.4%+34.4%
Range$193.00M$467.00M
CAGR+8.5%
Avg YoY Growth+14.8%
Median YoY Growth+13.0%

Frequently Asked Questions

What is Boston Scientific's other?
Boston Scientific (BSX) reported other of $379.00M in Q3 2025.
How has Boston Scientific's other changed year-over-year?
Boston Scientific's other increased by 34.4% year-over-year, from $282.00M to $379.00M.
What is the long-term trend for Boston Scientific's other?
Over 4 years (2020 to 2024), Boston Scientific's other has grown at a 0.5% compound annual growth rate (CAGR), from $307.00M to $313.00M.